PubRank

Younghyoun Yoon

Author PubWeight™ 15.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 2005 2.59
2 CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun 2007 1.96
3 Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 2009 1.75
4 Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem Biophys Res Commun 2007 1.40
5 Development of a unique small molecule modulator of CXCR4. PLoS One 2012 1.18
6 Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha. Biochem Biophys Res Commun 2006 1.15
7 Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity. J Med Chem 2010 1.08
8 Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol 2011 0.98
9 Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis. PLoS One 2013 0.92
10 Early prediction of response to Vorinostat in an orthotopic rat glioma model. NMR Biomed 2012 0.87
11 Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitors. ChemMedChem 2013 0.85
12 Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties. J Med Chem 2013 0.80